BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15525344)

  • 1. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin.
    Wang X; Zhu C; Wang X; Gerwien JG; Schrattenholz A; Sandberg M; Leist M; Blomgren K
    J Neurochem; 2004 Nov; 91(4):900-10. PubMed ID: 15525344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and its derivative protect the intestine from severe ischemia/reperfusion injury in the rat.
    Mori S; Sawada T; Okada T; Kubota K
    Surgery; 2008 Apr; 143(4):556-65. PubMed ID: 18374054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asialoerythropoietin has strong renoprotective effects against ischemia-reperfusion injury in a murine model.
    Okada T; Sawada T; Kubota K
    Transplantation; 2007 Aug; 84(4):504-10. PubMed ID: 17713435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats.
    Spandou E; Papadopoulou Z; Soubasi V; Karkavelas G; Simeonidou C; Pazaiti A; Guiba-Tziampiri O
    Brain Res; 2005 May; 1045(1-2):22-30. PubMed ID: 15910759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asialoerythropoietin, a nonerythropoietic derivative of erythropoietin, displays broad anti-heart failure activity.
    Takeyama T; Takemura G; Kanamori H; Kawaguchi T; Ogino A; Watanabe T; Morishita K; Tsujimoto A; Goto K; Maruyama R; Ushikoshi H; Kawasaki M; Yamada K; Nikami H; Fujiwara T; Fujiwara H; Minatoguchi S
    Circ Heart Fail; 2012 Mar; 5(2):274-85. PubMed ID: 22343033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of Shenfu injection on hypoxic-ischemic brain damage: experiment with neonatal rats].
    Wang J; Yang LJ; Zhou CM; Zhu HM; Zhang SM
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2994-7. PubMed ID: 17288814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative.
    Grasso G; Sfacteria A; Erbayraktar S; Passalacqua M; Meli F; Gokmen N; Yilmaz O; La Torre D; Buemi M; Iacopino DG; Coleman T; Cerami A; Brines M; Tomasello F
    J Neurosurg Spine; 2006 Apr; 4(4):310-8. PubMed ID: 16619678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asialoerythropoietin attenuates neuronal cell death in the hippocampal CA1 region after transient forebrain ischemia in a gerbil model.
    Yamashita T; Nonoguchi N; Ikemoto T; Miyatake S; Kuroiwa T
    Neurol Res; 2010 Nov; 32(9):957-62. PubMed ID: 20444326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subventricular zone-derived oligodendrogenesis in injured neonatal white matter in mice enhanced by a nonerythropoietic erythropoietin derivative.
    Kako E; Kaneko N; Aoyama M; Hida H; Takebayashi H; Ikenaka K; Asai K; Togari H; Sobue K; Sawamoto K
    Stem Cells; 2012 Oct; 30(10):2234-47. PubMed ID: 22890889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives.
    Villa P; van Beek J; Larsen AK; Gerwien J; Christensen S; Cerami A; Brines M; Leist M; Ghezzi P; Torup L
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):552-63. PubMed ID: 16835629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin protects against apoptosis and increases expression of non-neuronal cell markers in the hypoxia-injured developing brain.
    Yamada M; Burke C; Colditz P; Johnson DW; Gobe GC
    J Pathol; 2011 May; 224(1):101-9. PubMed ID: 21404277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
    Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
    Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat.
    Svedin P; Guan J; Mathai S; Zhang R; Wang X; Gustavsson M; Hagberg H; Mallard C
    Dev Neurosci; 2007; 29(4-5):393-402. PubMed ID: 17762207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain.
    Spandou E; Papoutsopoulou S; Soubasi V; Karkavelas G; Simeonidou C; Kremenopoulos G; Guiba-Tziampiri O
    Brain Res; 2004 Sep; 1021(2):167-72. PubMed ID: 15342264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen gas is ineffective in moderate and severe neonatal hypoxia-ischemia rat models.
    Matchett GA; Fathali N; Hasegawa Y; Jadhav V; Ostrowski RP; Martin RD; Dorotta IR; Sun X; Zhang JH
    Brain Res; 2009 Mar; 1259():90-7. PubMed ID: 19168038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model.
    Cai J; Kang Z; Liu K; Liu W; Li R; Zhang JH; Luo X; Sun X
    Brain Res; 2009 Feb; 1256():129-37. PubMed ID: 19063869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of erythropoietin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice.
    Fan X; Heijnen CJ; van der KOOIJ MA; Groenendaal F; van Bel F
    Pediatr Res; 2011 Jan; 69(1):56-61. PubMed ID: 20856165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain.
    Cai Z; Lin S; Fan LW; Pang Y; Rhodes PG
    Neuroscience; 2006; 137(2):425-35. PubMed ID: 16289838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Shenmai injection on expression of hypoxia-inducible factor-1alpha in hypoxic-ischemic brain damage: experiment with rats].
    Wang W; Wang J; He YF; Chen QE; Zhu HM; Zhou CM; Zhang SM
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(16):1144-7. PubMed ID: 19595151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin receptor signaling mitigates renal dysfunction-associated heart failure by mechanisms unrelated to relief of anemia.
    Ogino A; Takemura G; Kawasaki M; Tsujimoto A; Kanamori H; Li L; Goto K; Maruyama R; Kawamura I; Takeyama T; Kawaguchi T; Watanabe T; Moriguchi Y; Saito H; Fujiwara T; Fujiwara H; Minatoguchi S
    J Am Coll Cardiol; 2010 Nov; 56(23):1949-58. PubMed ID: 21109120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.